Literature DB >> 22197470

The benefits of risk assessment tools for prostate cancer.

Ian M Thompson, Donna P Ankerst.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22197470      PMCID： PMC5034859          DOI： 10.1016/j.eururo.2011.12.012

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  5 in total

1.  Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors:  Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Ziding Feng; Howard L Parnes; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2006-04-19       Impact factor: 13.506

2.  Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality.

Authors:  Emil Scosyrev; Edward M Messing; Supriya Mohile; Dragan Golijanin; Guan Wu
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

3.  A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness.

Authors:  Lori J Sokoll; Martin G Sanda; Ziding Feng; Jacob Kagan; Isaac A Mizrahi; Dennis L Broyles; Alan W Partin; Sudhir Srivastava; Ian M Thompson; John T Wei; Zhen Zhang; Daniel W Chan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

Review 4.  Risk-based prostate cancer screening.

Authors:  Xiaoye Zhu; Peter C Albertsen; Gerald L Andriole; Monique J Roobol; Fritz H Schröder; Andrew J Vickers
Journal:  Eur Urol       Date:  2011-11-24       Impact factor: 20.096

5.  Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.

Authors:  M Scott Lucia; Amy K Darke; Phyllis J Goodman; Francisco G La Rosa; Howard L Parnes; Leslie G Ford; Charles A Coltman; Ian M Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2008-05-18
  5 in total
  2 in total

1.  Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.

Authors:  Donna P Ankerst; Andreas Boeck; Stephen J Freedland; J Stephen Jones; Angel M Cronin; Monique J Roobol; Jonas Hugosson; Michael W Kattan; Eric A Klein; Freddie Hamdy; David Neal; Jenny Donovan; Dipen J Parekh; Helmut Klocker; Wolfgang Horninger; Amine Benchikh; Gilles Salama; Arnauld Villers; Daniel M Moreira; Fritz H Schröder; Hans Lilja; Andrew J Vickers; Ian M Thompson
Journal:  World J Urol       Date:  2012-04-22       Impact factor: 4.226

Review 2.  Risk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detection.

Authors:  Igor Sorokin; Badar M Mian
Journal:  Asian J Androl       Date:  2015 Nov-Dec       Impact factor: 3.285
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.